Home › Funds › Renaissance Technologies › NTLA
Renaissance Technologies position in NTLA
INTELLIA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.40M sh
Reported value held$23.69M
Portfolio Weight0.03%
First reportedQ2 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 119.60K | $6.19M | New |
| Q1 2023 | 16.55K | $617 | New |
| Q4 2023 | 13.40K | $408 | New |
| Q2 2024 | 38.70K | $866.11K | New |
| Q4 2024 | 98.70K | $1.15M | New |
| Q2 2025 | 676.90K | $6.35M | New |
| Q3 2025 | 651.00K | $11.24M | Reduce |
| Q4 2025 | 1.67M | $15.04M | Add |
| Q2 2026 | 1.40M | $23.69M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NTLA
- ARK Invest 16.88M sh · $285.54M · Q2 2026
- BlackRock Inc 15.41M sh · $260.72M · Q2 2026
- Vanguard Group 13.01M sh · $116.96M · Q4 2025
- D. E. Shaw & Co 6.44M sh · $109.02M · Q2 2026
- Two Sigma Investments 5.24M sh · $88.58M · Q2 2026
- Fidelity Management & Research (FMR) 4.77M sh · $80.76M · Q2 2026
- Geode Capital Management 3.63M sh · $61.45M · Q2 2026
- Arrowstreet Capital 3.28M sh · $55.51M · Q2 2026
- UBS Group AG 2.45M sh · $41.39M · Q2 2026
- Goldman Sachs Group 2.26M sh · $38.31M · Q2 2026
- Morgan Stanley 1.73M sh · $29.30M · Q2 2026